Local News Magnolia Medical Announces $46 Million Growth Equity FinancingMagnolia Medical Technologies | February 23, 2022Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to…dcorriganFebruary 23, 2022 Read More
Local News MRI May Lower Breast Cancer Death from Variants in Three GenesUW Medicine | February 22, 2022Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more…dcorriganFebruary 22, 2022 Read More
Local News UW/Fred Hutch CFAR Announces New Co-Director of the Center & New Director of the Biometrics CoreUW/Fred Hutch Center for AIDS Research | February 18, 2022The UW/Fred Hutch Center for AIDS Research (CFAR) has announced that their search process for…dcorriganFebruary 18, 2022 Read More
Local News The ‘Golden Age’ for Research Tools: Parse Biosciences Raises $41.5M for Single-Cell TechGeekWire | February 17, 2022Alex Rosenberg was a postdoc at the University of Washington when he co-founded a new biotech…dcorriganFebruary 17, 2022 Read More
Local News Davis Lab Examines a Protein With a Key Role in ScarringInstitute for Stem Cell & Regenerative Medicine | February 17, 2022When an injury occurs, the body reacts immediately. Cells in the vicinity of the trauma…dcorriganFebruary 17, 2022 Read More
Local News Astellas and Seagen Announce Initial Results of PADCEV® (Enfortumab Vedotin-Ejfv) in Patients with Muscle-Invasive Bladder Cancer Not Eligible for Cisplatin ChemotherapySeagen | February 16, 2022Astellas Pharma US and Seagen, Inc. announced the initial results from Cohort H of the EV-103…dcorriganFebruary 16, 2022 Read More
Local News ‘Closing the Gap’ Paper Examines BBI’s Progress Toward Resolving Genetic Variants of Unknown SignificanceBrotman Baty Institute | February 16, 2022Shawn Fayer was in a coffee shop in Boston in 2017 when he read those…dcorriganFebruary 16, 2022 Read More
Local News Curevo Nets $60M for Adjuvant-Saving Shingles VaccineBioSpace | February 11, 2022Curevo Vaccine has secured $60 million in Series A financing. Curevo, a clinical-stage biotechnology company, is developing…dcorriganFebruary 11, 2022 Read More
Local News SEngine Precision Medicine and Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment for Aggressive and Untreatable TumorsBusiness Wire | February 11, 2022SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs on patient-derived…dcorriganFebruary 11, 2022 Read More
Local News How Does Leukemia Escape from Immunotherapy?Fred Hutch | February 10, 2022When an experimental new cancer treatment shows promising results for many patients, these successes are…dcorriganFebruary 10, 2022 Read More